Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome
- PMID: 26499447
- PMCID: PMC4736733
- DOI: 10.1002/oby.21371
Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome
Abstract
Objective: Dietary fructose is implicated in metabolic syndrome, but intervention studies are confounded by positive caloric balance, changes in adiposity, or artifactually high amounts. This study determined whether isocaloric substitution of starch for sugar would improve metabolic parameters in Latino (n = 27) and African-American (n = 16) children with obesity and metabolic syndrome.
Methods: Participants consumed a diet for 9 days to deliver comparable percentages of protein, fat, and carbohydrate as their self-reported diet; however, dietary sugar was reduced from 28% to 10% and substituted with starch. Participants recorded daily weights, with calories adjusted for weight maintenance. Participants underwent dual-energy X-ray absorptiometry and oral glucose tolerance testing on Days 0 and 10. Biochemical analyses were controlled for weight change by repeated measures ANCOVA.
Results: Reductions in diastolic blood pressure (-5 mmHg; P = 0.002), lactate (-0.3 mmol/L; P < 0.001), triglyceride, and LDL-cholesterol (-46% and -0.3 mmol/L; P < 0.001) were noted. Glucose tolerance and hyperinsulinemia improved (P < 0.001). Weight reduced by 0.9 ± 0.2 kg (P < 0.001) and fat-free mass by 0.6 kg (P = 0.04). Post hoc sensitivity analysis demonstrates that results in the subcohort that did not lose weight (n = 10) were directionally consistent.
Conclusions: Isocaloric fructose restriction improved surrogate metabolic parameters in children with obesity and metabolic syndrome irrespective of weight change.
© 2015 The Obesity Society.
Figures
Comment in
-
Nutrition: Breaking the fructose habit.Nat Rev Endocrinol. 2016 Jan;12(1):3. doi: 10.1038/nrendo.2015.197. Epub 2015 Nov 20. Nat Rev Endocrinol. 2016. PMID: 26585657 No abstract available.
-
Response to "Metabolic improvement with fructose restriction: Is it the fructose or the weight loss?".Obesity (Silver Spring). 2016 Mar;24(3):550. doi: 10.1002/oby.21438. Epub 2016 Feb 8. Obesity (Silver Spring). 2016. PMID: 26853905 No abstract available.
-
Metabolic improvement with fructose restriction: Is it the fructose or the weight loss?Obesity (Silver Spring). 2016 Mar;24(3):549. doi: 10.1002/oby.21431. Epub 2016 Feb 9. Obesity (Silver Spring). 2016. PMID: 26857209 No abstract available.
Similar articles
-
Short-term isocaloric fructose restriction lowers apoC-III levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome.Atherosclerosis. 2016 Oct;253:171-177. doi: 10.1016/j.atherosclerosis.2016.06.048. Epub 2016 Jul 19. Atherosclerosis. 2016. PMID: 27451002 Clinical Trial.
-
Isocaloric Fructose Restriction Reduces Serum d-Lactate Concentration in Children With Obesity and Metabolic Syndrome.J Clin Endocrinol Metab. 2019 Jul 1;104(7):3003-3011. doi: 10.1210/jc.2018-02772. J Clin Endocrinol Metab. 2019. PMID: 30869790 Free PMC article.
-
Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity.Gastroenterology. 2017 Sep;153(3):743-752. doi: 10.1053/j.gastro.2017.05.043. Epub 2017 Jun 1. Gastroenterology. 2017. PMID: 28579536 Free PMC article.
-
Diet patterns, adipokines, and metabolism: where are we and what is next?Metabolism. 2014 Feb;63(2):168-77. doi: 10.1016/j.metabol.2013.11.004. Epub 2013 Nov 12. Metabolism. 2014. PMID: 24360751 Review. No abstract available.
-
Sugar consumption, metabolic disease and obesity: The state of the controversy.Crit Rev Clin Lab Sci. 2016;53(1):52-67. doi: 10.3109/10408363.2015.1084990. Epub 2015 Sep 17. Crit Rev Clin Lab Sci. 2016. PMID: 26376619 Free PMC article. Review.
Cited by
-
Angiopoietin-like Proteins and Lipoprotein Lipase: The Waltz Partners That Govern Triglyceride-Rich Lipoprotein Metabolism? Impact on Atherogenesis, Dietary Interventions, and Emerging Therapies.J Clin Med. 2024 Sep 4;13(17):5229. doi: 10.3390/jcm13175229. J Clin Med. 2024. PMID: 39274442 Free PMC article.
-
Assessing the impact of concurrent high-fructose and high-saturated fat diets on pediatric metabolic syndrome: A review.World J Clin Pediatr. 2024 Jun 9;13(2):91478. doi: 10.5409/wjcp.v13.i2.91478. eCollection 2024 Jun 9. World J Clin Pediatr. 2024. PMID: 38947987 Free PMC article. Review.
-
The chylomicron saga: time to focus on postprandial metabolism.Front Endocrinol (Lausanne). 2024 Jan 18;14:1322869. doi: 10.3389/fendo.2023.1322869. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38303975 Free PMC article. Review.
-
The Impact and Burden of Dietary Sugars on the Liver.Hepatol Commun. 2023 Nov 6;7(11):e0297. doi: 10.1097/HC9.0000000000000297. eCollection 2023 Nov 1. Hepatol Commun. 2023. PMID: 37930128 Free PMC article. Review.
-
Sugar and Dyslipidemia: A Double-Hit, Perfect Storm.J Clin Med. 2023 Aug 31;12(17):5660. doi: 10.3390/jcm12175660. J Clin Med. 2023. PMID: 37685728 Free PMC article. Review.
References
-
- Sorof JM, Lai D, Turner J, Poffenbarger T, Portman RJ. Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics. 2004;113:475–482. - PubMed
-
- Kohen-Avramoglu R, Theriault A, Adeli K. Emergence of the metabolic syndrome in childhood: an epidemiological overview and mechanistic link to dyslipidemia. Clin Biochem. 2003;36:413–420. - PubMed
-
- Schwimmer JB, Deutsch R, Rauch JB, Behlung C, Newbury R, Lavine JE. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr. 2005;143:500–505. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
